US Fertility

OOVA is a fertility diagnostic company that develops a personalized fertility assessment platform based on a paper-based urine test strip that measures hormones in daily samples. The system builds a longitudinal fertility profile using biochemistry and artificial intelligence to guide cycle management, menstrual health after pregnancy, and progression toward menopause. Originating as a spin-out from Mount Sinai Hospital in New York, OOVA aims to help users understand pregnancy prospects, identify reasons for conception challenges, and detect reproductive health issues such as PCOS. Its test kit measures luteinizing hormone and progesterone over a short window, with results delivered through a mobile application to support wellness guidance for users and input for healthcare providers. Founded in 2017 and based in New York, the company focuses on consumer-accessible diagnostics designed to empower women in conceiving and monitoring reproductive health.

Ovation Fertility is a network of IVF labs, genetics labs, and partner physician practices dedicated to delivering superior assisted reproductive technology services. It aggregates leading experts in reproductive medicine, committed to applying cutting-edge techniques and patient care.